Danielle Meyrick

Danielle Meyrick, PhD, MD, is currently the Chief Scientific Officer at GenesisCare, where they co-lead the clinical and scientific strategy focused on radiopharmaceutical clinical trials. They also serve as Deputy Chair and Chair of the Clinical Governance Committee at Breast Cancer Care WA, and as a Director and Co-Founder of EPIC Theranostics. Previously, they held leadership roles in various institutions, including Deputy School Dean at Murdoch University and Councillor at AINSE Limited, where they facilitated governance and collaboration in nuclear science. Danielle earned a Doctor of Medicine from The University of Western Australia and is pursuing further studies in Mineral Science and Radiochemistry at Murdoch University.